CFO4Life Group LLC Increases Position in Johnson & Johnson $JNJ

CFO4Life Group LLC grew its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 16.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,676 shares of the company’s stock after buying an additional 1,522 shares during the quarter. CFO4Life Group LLC’s holdings in Johnson & Johnson were worth $1,631,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. GFG Capital LLC bought a new stake in shares of Johnson & Johnson during the second quarter worth $35,000. Stone House Investment Management LLC bought a new stake in Johnson & Johnson during the 1st quarter valued at about $47,000. 1248 Management LLC purchased a new stake in Johnson & Johnson in the 1st quarter valued at about $48,000. Harvest Fund Management Co. Ltd bought a new position in Johnson & Johnson in the 1st quarter worth about $52,000. Finally, Pandora Wealth Inc. purchased a new position in shares of Johnson & Johnson during the first quarter worth approximately $65,000. Hedge funds and other institutional investors own 69.55% of the company’s stock.

Insider Activity

In other news, EVP Jennifer L. Taubert sold 56,471 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $177.81, for a total transaction of $10,041,108.51. Following the completion of the sale, the executive vice president owned 178,013 shares in the company, valued at approximately $31,652,491.53. This represents a 24.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.16% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Guggenheim raised Johnson & Johnson from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $167.00 to $206.00 in a research note on Tuesday, September 23rd. Johnson Rice set a $190.00 price target on Johnson & Johnson and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. JPMorgan Chase & Co. raised their price target on Johnson & Johnson from $185.00 to $200.00 and gave the company a “neutral” rating in a research note on Tuesday, September 16th. Stifel Nicolaus upped their price objective on shares of Johnson & Johnson from $165.00 to $190.00 and gave the stock a “hold” rating in a research note on Wednesday, October 15th. Finally, HSBC increased their target price on shares of Johnson & Johnson from $210.00 to $215.00 and gave the stock a “buy” rating in a report on Thursday, October 16th. Four research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $201.05.

Johnson & Johnson Trading Up 0.4%

Shares of NYSE JNJ opened at $196.00 on Friday. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $197.18. The business has a fifty day moving average price of $185.81 and a 200 day moving average price of $169.94. The stock has a market capitalization of $472.22 billion, a P/E ratio of 18.92, a price-to-earnings-growth ratio of 2.19 and a beta of 0.38. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Wednesday, August 30th. The company reported $2.26 earnings per share (EPS) for the quarter. The company had revenue of $24.02 billion for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%. Equities research analysts expect that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 25th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Tuesday, November 25th. Johnson & Johnson’s payout ratio is currently 50.19%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.